Activated lymphocytes as a metabolic model for carcinogenesis.
about
Targeting amino acid metabolism in cancer growth and anti-tumor immune responseT cell metabolism drives immunityImmunometabolism in TuberculosisDynamic Metabolism in Immune ResponseTRAF3 deficiency promotes metabolic reprogramming in B cellsReactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation.Lymphocyte glucose and glutamine metabolism as targets of the anti-inflammatory and immunomodulatory effects of exercise.Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells.Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposureThe Bioenergetic Health Index: a new concept in mitochondrial translational researchUncoupling protein 2 and 4 expression pattern during stem cell differentiation provides new insight into their putative function.How lipidomics provides new insight into drug discovery.Metformin inhibits gastric cancer via the inhibition of HIF1α/PKM2 signalingTargeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replicationInfection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs.AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and Survival.Metabolic requirements for cancer cell proliferationA review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkersTargeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.Targeting T cell metabolism for therapy.6-mercaptopurine promotes energetic failure in proliferating T cells.Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.Inhibition of the lymphocyte metabolic switch by the oxidative burst of human neutrophils.A comprehensive characterization of the impact of mycophenolic acid on the metabolism of Jurkat T cells.Bioenergetic analysis of human peripheral blood mononuclear cells.Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond.The 150 most important questions in cancer research and clinical oncology series: questions 86-93 : Edited by Chinese Journal of Cancer.Toxicity of cobalt-chromium nanoparticles released from a resurfacing hip implant and cobalt ions on primary human lymphocytes in vitro.Inhibition of Systemic Hyaluronan Synthesis Exacerbates Murine Hepatic Carcinogenesis.Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression.Experimental Periodontitis Results in Prediabetes and Metabolic Alterations in Brain, Liver and Heart: Global Untargeted Metabolomic Analyses
P2860
Q26775425-25D9A7D1-A64D-409F-A788-56ADB47AA955Q26799575-D8059EFB-A13A-4699-89DC-29B59F3AFE79Q27021247-793C1DF2-E294-47FE-8832-1C190532DCD5Q28391962-1C0546BF-7817-4E4E-B7EC-90537B14D228Q28820861-527D4F63-6FA1-4B09-AA7E-E6142303AF40Q33584702-610DE5CF-64C6-4168-9E40-A293715EB388Q33764981-DC39E302-48CC-4A0B-896F-5B82F19FA2ACQ34000160-92D7B551-6DE1-4982-9F57-7703775C14A2Q34249104-9054F9A1-0063-4B45-9620-F47E6A178A8AQ34368877-7C89A264-9794-4AEE-BE15-B28B88D2A8C8Q35093630-C519C390-AE2E-4C27-8411-0AE73AF7FD08Q35167171-124A7F1F-822E-40DE-BE6B-7DB713ABF578Q35758003-77FBBE52-1514-4FCF-B478-599F9F0233D2Q35836097-217064DE-6FEC-4578-81D4-944CF0208055Q36063046-59AFEE23-4BEF-4D07-98DD-39FE2872644BQ36360891-F8406DC0-F9E6-48E0-9DAB-E626CF86CC3DQ36800650-F3E1FB45-4C61-4783-836C-299AAE0CAAE5Q37185238-C0CF24CB-84BA-4E38-A1A2-A5C3C78BDA69Q37541024-042B68C5-76B5-49C6-BE78-84021C1D28F1Q38218127-190D0C7F-3616-497B-AF58-6FF3B27127CBQ38324388-D818CC12-D861-4B3D-A715-CEAA40300C3BQ38701511-6B7C4BC3-2B20-486B-8EB4-0E6C1389C897Q38973075-FF11C499-197A-47DA-8C16-1A9B95EEB28EQ39378337-D5A8EA3B-50E4-4281-85F2-D1835F821546Q39418546-A8EC6757-C67E-4B6A-B334-2AD575BFDCBAQ41251598-5C1411EF-845B-450A-A593-09C20BF6099AQ41620097-961B5970-C750-430F-A68C-46B54CE22236Q42477736-CAD40D30-682F-4CA3-8C34-320EEDA485F7Q46291182-0312CDF7-4E5E-48EC-8CFB-F0EDFA2DC2EBQ47550252-81DBF867-245C-4BD9-9BB9-4BDFA1BCCDF1Q50453204-47F5C651-4A92-4F73-90F2-416ECDEA4338Q53177828-FA705F3D-C835-4AB6-A03B-7CD3D18A51CEQ55386824-20AEF87E-0B14-41AF-99E3-3924D543CE76Q57140240-7C4E0F6A-A601-4CE3-BEB9-240EAEB37134
P2860
Activated lymphocytes as a metabolic model for carcinogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activated lymphocytes as a metabolic model for carcinogenesis.
@en
Activated lymphocytes as a metabolic model for carcinogenesis.
@nl
type
label
Activated lymphocytes as a metabolic model for carcinogenesis.
@en
Activated lymphocytes as a metabolic model for carcinogenesis.
@nl
prefLabel
Activated lymphocytes as a metabolic model for carcinogenesis.
@en
Activated lymphocytes as a metabolic model for carcinogenesis.
@nl
P2860
P356
P1433
P1476
Activated lymphocytes as a metabolic model for carcinogenesis
@en
P2093
Jeffrey C Rathmell
P2860
P2888
P356
10.1186/2049-3002-1-5
P577
2013-01-23T00:00:00Z
P5875
P6179
1033866501